New naturally derived antidiabetic compound preserves beta-cell function in preclinical studies Sep. 4, 2009
Adding colesevelam to a statin and ezetimibe lowers LDL-cholesterol in familial hypercholesterolemia Sep. 2, 2009
ACAT-2 inhibitors for the treatment of lipoprotein disorders disclosed by Kitasato Institute Sep. 2, 2009
Shire submits NDA to FDA for velaglucerase alfa and reports results from phase III trials Sep. 1, 2009
RSS